Correia Neuman, Mullally Sinead, Cooke Gillian, Tun Tommy Kyaw, Phelan Niamh, Feeney Joanne, Fitzgibbon Maria, Boran Gerard, O'Mara Shane, Gibney James
Department of Endocrinology and Diabetes, Adelaide and Meath Hospital, incorporating the National Children's Hospital, Tallaght, Dublin 24, Ireland.
J Clin Endocrinol Metab. 2009 Oct;94(10):3789-97. doi: 10.1210/jc.2008-2702. Epub 2009 Jul 7.
Declarative memory largely depends upon normal functioning temporal lobes (hippocampal complex) and prefrontal cortex. Animal studies suggest abnormal hippocampal function in hypothyroidism.
The aim of the study was to assess declarative memory in overt and subclinical (SCH) hypothyroid patients before and after l-T(4) (LT4) replacement and in matched normal subjects.
A prospective, open-labeled interventional study was conducted at a teaching hospital.
Hypothyroid (n = 21) and SCH (n = 17) patients underwent neuropsychological tests at baseline and 3 and 6 months after LT4 replacement. Normal subjects were studied at the same time-points.
Tests of spatial, verbal, associative, and working memory; attention; and response inhibition and the Hospital Anxiety and Depression Scale were administered.
Baseline deficits in spatial, associative, and verbal memory, which rely upon the integrity of the hippocampal and frontal areas, were identified in patients with overt hypothyroidism. Spatial and verbal memory were impaired in SCH patients (P < 0.05). TSH levels correlated negatively (P < 0.05) with these deficits. After LT4 replacement, verbal memory normalized. Spatial memory normalized in the SCH group but remained impaired in the hypothyroid group. Associative memory deficits persisted in the overt hypothyroid group. Hospital Anxiety and Depression Scale scores did not correlate with cognitive function. Measures of attention and response inhibition did not differ from control subjects.
Cognitive impairment occurs in SCH and more markedly in overt hypothyroidism. These impairments appear predominantly mnemonic in nature, suggesting that the etiology is not indicative of general cognitive slowing. We propose that these deficits may reflect an underlying disruption of normal hippocampal function and/or connectivity.
陈述性记忆很大程度上依赖于正常功能的颞叶(海马复合体)和前额叶皮质。动物研究表明甲状腺功能减退时海马功能异常。
本研究旨在评估显性和亚临床甲状腺功能减退患者在左甲状腺素(LT4)替代治疗前后以及匹配的正常受试者的陈述性记忆。
在一家教学医院进行了一项前瞻性、开放标签的干预性研究。
甲状腺功能减退患者(n = 21)和亚临床甲状腺功能减退患者(n = 17)在基线时以及LT4替代治疗后3个月和6个月接受神经心理学测试。正常受试者在相同时间点进行研究。
进行空间、言语、联想和工作记忆测试;注意力测试;反应抑制测试以及医院焦虑抑郁量表测试。
在显性甲状腺功能减退患者中发现了依赖于海马和额叶区域完整性的空间、联想和言语记忆的基线缺陷。亚临床甲状腺功能减退患者的空间和言语记忆受损(P < 0.05)。促甲状腺激素水平与这些缺陷呈负相关(P < 0.05)。LT4替代治疗后,言语记忆恢复正常。亚临床甲状腺功能减退组的空间记忆恢复正常,但甲状腺功能减退组仍受损。显性甲状腺功能减退组的联想记忆缺陷持续存在。医院焦虑抑郁量表评分与认知功能无关。注意力和反应抑制测试结果与对照组无差异。
亚临床甲状腺功能减退和显性甲状腺功能减退均会出现认知障碍,且显性甲状腺功能减退时更为明显。这些障碍主要表现为记忆方面,提示其病因并非一般性认知减慢。我们认为这些缺陷可能反映了正常海马功能和/或连接性的潜在破坏。